Defining the Role of Varicose Projection Astrocytes in Alzheimer's Disease Pathology
About This Grant
PROJECT SUMMARY Alzheimer’s disease (AD) is a progressive neurodegenerative disorder that remains without effective treatment. Mounting evidence suggests that neuroinflammation plays a critical role in AD progression, yet the contribution of astrocytes—a major glial cell type involved in brain homeostasis—remains poorly defined. Recent discoveries from our lab have identified varicose projection (VP) astrocytes as a novel, reactive astrocyte phenotype associated with neuroinflammatory conditions, including AD. Unlike traditional astrocytes, VP astrocytes display distinct morphological features (long processes with evenly spaced varicosities), are enriched in the cortex and white matter of AD brains, and can be experimentally induced in vitro by pro-inflammatory cytokines. Importantly, the VP astrocyte phenotype is reversible upon cytokine withdrawal, highlighting its potential as a targetable cellular response in AD. This AREA R15 project aims to elucidate the role of VP astrocytes in AD pathology using human-induced pluripotent stem cell (hiPSC)-based models and human postmortem brains. The project will engage undergraduate researchers at Towson University in Dr. Falcone’s lab and within a novel neuroscience Course- Based Undergraduate Research Experience (CURE). Here, we propose to investigate the role of VP astrocytes in AD pathology through two aims: (Aim 1) Define the molecular signature of VP astrocytes in AD-associated neuroinflammation using Patch-seq transcriptomic profiling and validation in human postmortem brain tissue; (Aim 2) Assess the functional impact of VP astrocytes on neuronal degeneration using hiPSC-derived neuron-astrocyte co-cultures, testing cytokine withdrawal and pharmacological inhibition of key inflammatory pathways. By integrating cellular, molecular and anatomical approaches in human-based models, this project will reveal the mechanistic contribution of VP astrocytes to AD, laying the groundwork for novel therapeutic strategies while training the next generation of biomedical scientists.
Grant Summary
Defining the Role of Varicose Projection Astrocytes in Alzheimer's Disease Pathology is a NIA - National Institute on Aging grant providing up to $471K for university, nonprofit, healthcare org. Applications are due 2029-07-31 (open). Check eligibility and apply with FindGrants.
Not quite the right fit?
Search 9,000+ open grants, or get matches ranked for your organization — free.
Focus Areas
Eligibility
How to Apply
Up to $471K
2029-07-31
- 1Confirm your organization is eligible for Defining the Role of Varicose Projection Astrocytes in Alzheimer's Disease Pathology from NIA - National Institute on Aging, checking organization type, location, and any population or project requirements.
- 2Gather the required documents and information, including your organization details, project plan, and budget figures.
- 3Draft your application narrative and budget addressing the funder's priorities and review criteria. FindGrants can draft each section for you to review and edit.
- 4Review every section against the requirements checklist, then export a submission-ready application pack and submit it to NIA - National Institute on Aging before the deadline.
Don't want to draft it yourself?
We'll draft the complete application against NIA - National Institute on Aging's requirements, run a quality review, and email you a submission-ready PDF plus an editable Word doc within 5 business days. Most orders deliver in 24-48 hours. Flat $399, any grant size.
AI Requirement Analysis
Detailed requirements not yet analyzed
Have the NOFO? Paste it below for AI-powered requirement analysis.
Defining the Role of Varicose Projection Astrocytes in Alzheimer's Disease Pathology: Frequently Asked Questions
Who is eligible for the Defining the Role of Varicose Projection Astrocytes in Alzheimer's Disease Pathology?
Defining the Role of Varicose Projection Astrocytes in Alzheimer's Disease Pathology is offered by NIA - National Institute on Aging and is generally open to university, nonprofit, healthcare org. It is open to organizations nationwide unless the funder specifies otherwise. Review the specific eligibility terms before applying, since funders set their own requirements around organization type, location, and the population or project being served.
How much funding does the Defining the Role of Varicose Projection Astrocytes in Alzheimer's Disease Pathology provide?
Defining the Role of Varicose Projection Astrocytes in Alzheimer's Disease Pathology provides up to $471K per award from NIA - National Institute on Aging. Actual award sizes depend on the scope of your project, available program funds, and the number of applicants, so build a budget that reflects realistic, allowable costs rather than the maximum figure.
When is the Defining the Role of Varicose Projection Astrocytes in Alzheimer's Disease Pathology deadline?
Applications for Defining the Role of Varicose Projection Astrocytes in Alzheimer's Disease Pathology are due 2029-07-31 (open). Because deadlines can change, verify the date with the funder, NIA - National Institute on Aging, and give yourself enough time to prepare a complete, competitive application before the close date.
How do you apply for the Defining the Role of Varicose Projection Astrocytes in Alzheimer's Disease Pathology?
To apply for Defining the Role of Varicose Projection Astrocytes in Alzheimer's Disease Pathology, confirm your eligibility, gather the required documents, and prepare a narrative and budget that address the funder's priorities. FindGrants guides you step by step and can draft each section, then exports a submission-ready application pack for this grant from NIA - National Institute on Aging.